Ann: Report on Tuberculosis Trials, page-33

When you go back to the announcements in June and November last year about the testing of Bluemist they are talking flow rate relative to the volume of the chamber. The chamber size was 22.65 M3 and the flow rate 200 M3/hr.

Testing in a 93 M2 area tells you nothing about the volume of air in the ward for the test in India. From the given volume ( 425 M3) it appears the ceiling was around 15 ft high. The last hospital ward I was in the ceiling was about 9ft high.

I would expect experts in the field of research not to make such a rookie error in testing as using M2 intead of M3 like previous tests.

@tukebay I'm not surprised at the blowout in time, just getting more grumpy as I get older with just about every stock I've invested in having timeline blowouts that the supposed experts in the field set themselves. I know in my business to business dealings, that if we had the same types of time blowouts as ASX listed companies have with shareholders, we would go out of business very quickly.

This part of the announcement ......."Ongoing due diligence (“DD” testing trials with Original Equipment Manufacturers (“OEM” have been primarily focused on the air purification system. They are now also extending to water treatment applications."

Especially the bold bit means more testing from the OEMs that have only started on the water treatment applications quite recently. My expectation is they will want to do some type of package deal for both air and water, so no 'air only' deal would be signed by any of them, so a longer time frame, perhaps by quite a few months.

At the AGM last year there was talk about how the OEMs all wanted exclusivity, but PO3 didn't want to go down that path, however a period of exclusivity could be a possibility. In this sort of context I wouldn't expect any OEM to want 'air' only products while a competitor had 'water' products, hence they want to test for 'water'. (it also confirms to me that they seem to be happy with the 'air' side of things).